SYN060 (adalimumab biosimilar) / Synermore - LARVOL DELTA

Comparison of the Safety and PK of SYN060 to Humira® in Healthy Adult Subjects (clinicaltrials.gov) - P1; N=90; Recruiting; Sponsor: Synermore Biologics Co., Ltd.; Trial primary completion date: Jun 2018 ➔ Dec 2018

Trial primary completion date • Biosimilar • Immunology • Rheumatoid Arthritis